Arcus Biosciences, Inc.

Home » Arcus Biosciences, Inc.

IPO

Arcus Biosciences, Inc.

They are a clinical-stage biopharmaceutical company focused on creating innovative cancer immunotherapies by leveraging underexploited biological opportunities.

Symbol

RCUS

Price Range
$13.00 - $15.00

Final Shares
7,100,000

Anticipated Date
TBD

Underwriters
Citigroup, Goldman Sachs & Co., Leerink Partners

To view the prospectus for Arcus Biosciences, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253